These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16609287)

  • 1. Diabetic nephropathy: leveraging mouse genetics.
    Breyer MD; Qi Z; Tchekneva E
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):227-32. PubMed ID: 16609287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the genetics of diabetic nephropathy through the study of mice.
    Breyer MD; Qi Z; Tchekneva EE; Harris RC
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):82-6. PubMed ID: 18090675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of diabetic nephropathy: lessons from mice.
    Breyer MD; Tchekneva E; Qi Z; Takahashi T; Fogo AB; Zhao HJ; Harris RC
    Semin Nephrol; 2007 Mar; 27(2):237-47. PubMed ID: 17418691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
    Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
    J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of diabetic nephropathy.
    Maeda S
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):363-71. PubMed ID: 19124434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
    Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
    J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards understanding the inherited susceptibility for nephropathy in diabetes.
    Thomas MC; Groop PH; Tryggvason K
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):195-202. PubMed ID: 22314557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression pattern of genes in peripheral blood mononuclear cells in diabetic nephropathy.
    Moczulski DK; Fojcik H; Wielgorecki A; Trautsolt W; Gawlik B; Kosiorz-Gorczynska S; Oczko-Wojciechowska M; Wiench M; Strojek K; Zukowska-Szczechowska E; Grzeszczak W
    Diabet Med; 2007 Mar; 24(3):266-71. PubMed ID: 17263765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of diabetic nephropathy.
    Breyer MD; Böttinger E; Brosius FC; Coffman TM; Harris RC; Heilig CW; Sharma K;
    J Am Soc Nephrol; 2005 Jan; 16(1):27-45. PubMed ID: 15563560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent models of streptozotocin-induced diabetic nephropathy.
    Tesch GH; Allen TJ
    Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine models of diabetic nephropathy.
    Peters V; Schmitt CP
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):191-3. PubMed ID: 22402945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice.
    Xiao X; Ma B; Dong B; Zhao P; Tai N; Chen L; Wong FS; Wen L
    J Autoimmun; 2009 Mar; 32(2):85-93. PubMed ID: 19200691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of HIV-associated nephropathy.
    Lu TC; He JC; Klotman P
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):233-7. PubMed ID: 16609288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of growth arrest-specific gene 6 in diabetic nephropathy.
    Arai H; Nagai K; Doi T
    Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.
    Sugimoto H; Grahovac G; Zeisberg M; Kalluri R
    Diabetes; 2007 Jul; 56(7):1825-33. PubMed ID: 17456853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects.
    Aigner B; Rathkolb B; Herbach N; Hrabé de Angelis M; Wanke R; Wolf E
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E232-40. PubMed ID: 18056790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.